A new left atrial appendage occluder (Lifetech LAmbreTM Device) for stroke prevention in atrial fibrillation

Cardiovascular Revascularization Medicine

Volumn 14, Issue 3, 2013, Pages 134-136

  Lam, Yat Yin ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Interventional Cardiology; Left Atrial Appendage Occluder; Stroke

Indexed keywords

HEPARIN; NITINOL;

ARTICLE; ATRIAL SEPTAL OCCLUDER; BRAIN ISCHEMIA; CARDIAC PATIENT; DRUG DELIVERY SYSTEM; HEART ATRIUM FIBRILLATION; HUMAN; IMPLANTATION; NITINOL STENT; PRIORITY JOURNAL;

ALLOYS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; CARDIAC CATHETERS; HUMANS; POLYESTERS; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; STROKE; TREATMENT OUTCOME;

EID: 84879251200     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2013.04.003     Document Type: Article

References (10)

1. Gallagher A.M., Setakis E., Plumb J.M., Clemens A., van Staa T.P. Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost 2011, 106:968-977.
2. Sievert H., Lesh M.D., Trepels T., et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 2002, 105:1887-1889.
3. Block P.C., Burstein S., Casale P.N., et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) study. JACC Cardiovasc Interv 2009, 2:594-600.
4. Sick P.B., Schuler G., Hauptmann K.E., et al. Initial worldwide experience with the watchman left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007, 49:1490-1495.
5. Park J.W., Bethencourt A., Sievert H., et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv 2011, 77:700-706.
6. Lam Y.Y., Ma T.K., Yan B.P. Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation. Int J Cardiol 2011, 150:4-11.
7. Holmes D.R., Reddy V.Y., Turi Z.G., et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized non-inferiority trial. Lancet 2009, 374:534-542.
8. Reddy V.Y., Holmes D., Doshi S.K., Neuzil P., Kar S. Safety of percutaneous left atrial appendage closure: results from the watchman left atrial appendage system for embolic protection in patients with AF (PROTECT-AF) clinical trial and the continued access registry. Circulation 2011, 123:417-424.
9. Lam Y.Y., Yip G.W., Yu C.M., et al. Left atrial appendage closure with Amplatzer cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv 2012, 79:794-800.
10. Cruz-Gonzalez I., Yan B.P., Lam Y.Y. Left atrial appendage exclusion: state-of-the-art. Catheter Cardiovasc Interv 2010, 75:806-813.